Treatment of benign epilepsy syndromes throughout life

L J Willmore1

  • 1Department of Neurology, Saint Louis University School of Medicine, St Louis, Missouri, USA. willmore@slu.edu

Epilepsia
|March 21, 2002
PubMed

Insights

Epilepsy classification helps identify benign syndromes. While childhood absence epilepsy often resolves, some cases evolve to juvenile myoclonic epilepsy (JME), requiring lifelong treatment.

Area of Science:

  • Neurology
  • Clinical Medicine
  • Epileptology

Background:

  • Epilepsy classification has advanced, enabling identification of syndromes with generally benign prognoses.
  • Certain epilepsy syndromes, like childhood absence epilepsy and benign epilepsy with centrotemporal spikes (BECTS), present unique treatment challenges.
  • Some epilepsy forms require long-term management, while others have favorable outcomes with minimal intervention.

Purpose of the Study:

  • To review the classification and prognostic implications of various epilepsy syndromes.
  • To discuss the diagnostic criteria and treatment considerations for specific epilepsy types.
  • To highlight the importance of long-term observation in managing pediatric and adult seizure disorders.

Main Methods:

  • Review of clinical patterns and electroencephalographic findings in different epilepsy syndromes.
  • Analysis of treatment outcomes and prognostic indicators for various seizure types.
  • Discussion of diagnostic challenges and therapeutic decision-making processes.

Main Results:

  • Childhood absence epilepsy often has a benign course, but 40% may progress to juvenile myoclonic epilepsy (JME), necessitating lifelong treatment.
  • Benign epilepsy with centrotemporal spikes (BECTS) is typically benign, often requiring no treatment or brief medication.
  • Familial partial seizures in adolescents and post-infarction seizures in the elderly generally follow benign courses.

Conclusions:

  • Accurate epilepsy classification aids in predicting outcomes and guiding treatment strategies.
  • Long-term patient observation is crucial for confirming normal development and making informed treatment decisions.
  • Clinical judgment and individual clinician experience play significant roles in managing rare benign epilepsy syndromes due to limited prospective studies.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.